Sat.Oct 19, 2024 - Fri.Oct 25, 2024

article thumbnail

Pumping the unemployed with weight-loss drugs echoes Victorian attitudes to the poor | Kenan Malik

The Guardian - Pharmaceutical Industry

Shifting blame to the victims of economic policy is an old trick by politicians. Now they’re using obesity to tackle joblessness In early 2023, Lars Fruergaard Jørgensen, chief executive of the Danish pharmaceutical company Novo Nordisk, and its UK corporate vice-president Pinder Sahota, met in Whitehall with the then health secretary Steve Barclay, England’s chief medical officer, Prof Chris Whitty, and various health and Treasury officials.

article thumbnail

Efficacy of Immunization for Pediatric Health Outcomes, Antibiotic Use | IDWeek 2024

Drug Topics

Researchers explored the overall efficacy of various pediatric vaccines and their effects on antibiotic use, while also addressing vaccine hesitancy among parents.

112
112
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

RK-33 May Be Significant in Treatment of Breast Cancer Bone Metastasis

Pharmacy Times

In a study, RK-33 demonstrated positive effects against the protein DDX3, which is key in the growth of cancer cells and spreading of disease.

73
article thumbnail

The Bible’s Different Perspective

The Honest Apothecary

One challenge that modern students of the Bible will encounter is that it presents a very different perspective on the way we should think about life. For example, the other day while scrolling through some social media accounts, I saw a post that simply said, “Maintain a very high opinion of yourself.” Clearly this insight […] The post The Bible’s Different Perspective appeared first on The Honest Apothecary.

69
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

STAT+: Perplexing results from Duchenne muscular dystrophy trial raise questions about gene therapies 

STAT

Confounding data from a Pfizer clinical trial has rattled the field of gene therapy for Duchenne muscular dystrophy, raising more questions about the regulatory standard used to approve a treatment from Sarepta Therapeutics, and complicating plans for other companies hoping to develop next-generation products.  Scientifically, Pfizer’s gene therapy did what it was supposed to do.

83
article thumbnail

STI Stigmatization, Misinformation in the Media | IDWeek 2024

Drug Topics

Researchers explored the stigmatization of sexually transmitted infections across film while also identifying inaccuracies in STI-related content on Tik Tok.

98

More Trending

article thumbnail

Free Psychiatric Pharmacotherapy Quiz

Med Ed 101

In this 10-question psychiatric Pharmacotherapy quiz, we cover antipsychotic use and bipolar pharmacotherapy. If you are looking for a practice exam for the BCPP (Board Certified Psychiatric Pharmacist) exam, you can find that here. If you are looking for comprehensive study guides on the BCPS, BCACP, BCGP, BCMTMS, or NAPLEX exams, feel free to check […] The post Free Psychiatric Pharmacotherapy Quiz appeared first on Med Ed 101.

52
article thumbnail

STAT+: Former FDA lawyers join tobacco industry in ‘epic’ fight against the agency

STAT

STAT is publishing this investigation in partnership with The Examination. Perham Gorji was a career government lawyer, helping to lead the Food and Drug Administration’s battle against tobacco and e-cigarettes.  He was there as the agency contemplated a ban on menthol cigarettes, and as vapes of all shapes and sizes flooded the market, hooking a new generation on nicotine.

FDA 82
article thumbnail

Weekend ICYMI: October 14 to October 18

Drug Topics

In case you missed it, this week we had stories about medication adherence and breast cancer outcomes, new vaccines in the pipeline, independent pharmacies saying no to Medicare drug price, and more.

article thumbnail

Eplontersen recommended for EU approval by CHMP for treatment of hereditary transthyretin-mediated amyloidosis

Pharmafile

Wainzua (eplotersen), produced by AstraZeneca and Ionis, has been recommended for approval in the European Union (EU) by the European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP). The drug will be used as a treatment for hereditary transthyretin-mediated amyloidosis in adult patients who have stage 1 or 2 polyneuropathy (commonly referred […] The post Eplontersen recommended for EU approval by CHMP for treatment of hereditary transthyretin-mediated amylo

64
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Can You Start Running After 50? Yes!

The Honest Apothecary

Can you start running after 50? Yes, you can. I was never much into running. Basketball was my game in high school. I only ran if there was a hoop at the other end of the court, or maybe a taco. Then I moved into a profession that initially had me standing and moving a […] The post Can You Start Running After 50? Yes! appeared first on The Honest Apothecary.

52
article thumbnail

After shingles damaged her vision, this former eye surgeon looked for a way to keep it from happening to others

STAT

It began with a burning pain in her right eye. At first, Elisabeth Cohen thought she’d gotten something in it. But the next day, as she was pushing her hair back on that side of her head, she noticed a blister near the hairline. She knew immediately what it was: shingles.  At the time, in 2008, Cohen was director of the Cornea Service at Wills Eye Hospital in Philadelphia.

article thumbnail

Small Doses: October 14 to October 18

Drug Topics

Check out a recap of important pharmacy news you might have missed this week, dispensed in small doses.

98
article thumbnail

HLTH24: Here’s a first look at a draft 'nutrition label' for health AI

Fierce Healthcare

LAS VEGAS—The Coalition for Health AI unveiled the first applied model card, completed by AI imaging company Aidoc. | The Coalition for Health AI released a draft of their AI model card, or “nutrition label” for AI, filled out with information from AI imaging company Aidoc. CHAI's work is part of ongoing efforts to ensure the responsible use of AI in healthcare.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Roche trial confirms Vabysmo efficacy in minorities

pharmaphorum

A study has shown that Roche's diabetic macular oedema (DME) therapy Vabysmo is effective in patients who identify as African American, Black, Hispanic and Latino, plugging a gap in the data for the drug.Vabysmo (faricimab) has been approved by the FDA for treating DME since 2022, quickly becoming one of the Swiss pharma group's fastest-growing products with sales of $1.1 billion in the first half of the year.

FDA 60
article thumbnail

STAT+: Behind CVS CEO’s ouster, a question: Do a pharmacy and a health insurer make sense together?

STAT

Does it make sense for a chain of drug stores to own a major health insurance company? That has been the existential question for CVS Health for six years, since its $70 billion acquisition of the massive insurer Aetna. The biggest pharmacy chain in the U.S. had already been moving beyond retail since its 2007 deal for pharmacy benefit manager Caremark.

77
article thumbnail

Now Trending: CVS CEO Steps Down, COVID-19 Racial Disparities

Drug Topics

Check out this recap of articles published on our sister sites during the past week.

98
article thumbnail

Study: Researchers Reveal New Images of RSV, Offering Further Treatment Options

Pharmacy Times

The connection of F proteins could help destabilize the virus prior to infection of the next host.

65
article thumbnail

Latin labelling on cosmetics is a risk to food allergy sufferers, says MP

The Guardian - Pharmaceutical Industry

Becky Gittins calls for cosmetic firms to list ingredients in English, saying current labelling is ‘absolutely bonkers’ Cosmetic companies need to stop forcing people with food allergies to learn Latin to safeguard their health and display warnings written in plain English, according to an MP with a history of severe allergic reactions who is demanding a step change in how sufferers are treated.

article thumbnail

STAT+: Seaport Therapeutics adds another $225 million to coffers to embrace the ‘golden age of neuroscience’

STAT

Seaport Therapeutics, the startup launched earlier this year by the team behind Karuna Therapeutics, has raised another $225 million just six months after its most recent fundraising round. Seaport raised the Series B funds from General Atlantic, Foresite Capital, T. Rowe Price Associates, and other investors. The startup, which is based in Boston, is developing a new cohort of what executives hope will be faster-acting, more effective treatments for depression, anxiety, and other mental health

77
article thumbnail

Nonopioid Suzetrigine Demonstrates Positive Phase 3 Results for Acute Pain | ASA 2024

Drug Topics

Suzetrigine could represent the first new nonopioid drug in a distinct class of pain medications in approximately 20 years.

86
article thumbnail

FDA Approves Companion Diagnostic To Identify Patients With Grade 2 IDH-Mutant Glioma Eligible for Vorasidenib

Pharmacy Times

The diagnostic test is a companion to vorasidenib, an isocitrate dehydrogenase inhibitor that received FDA approval this past summer.

FDA 65
article thumbnail

Happy National Pharmacy Week!

OctariusRx

Happy Pharmacy Week to our team members and colleagues! Each year during the third full week in October, we celebrate National Pharmacy Week, and I’d like to take the time to thank our Consultant Pharmacists, as well as supporting team members. In a world where integrity and values matter more than ever, you stand as shining examples of what our company represents.

article thumbnail

STAT+: Pharma execs donated more to Democrats in campaign’s final stretch

STAT

WASHINGTON — Most executives at pharmaceutical companies haven’t directly donated to political candidates over the final stretch of the 2024 campaign. But those who have largely gave to Democrats.  A STAT review of contributions by CEOs of member companies and board members of the brand drug lobby PhRMA showed most executives just gave to their companies’ political action committees, if they gave at all.

68
article thumbnail

Q&A: What Pharmacists Need to Know about Onyda XR for the Treatment of ADHD

Drug Topics

A conversation with Rakesh Jain, MD, MPH, clinical professor in the Department of Psychiatry at Texas Tech University School of Medicine.

76
article thumbnail

Expecting the Unexpected

Pharmaceutical Commerce

In this video interview with Pharma Commerce Editor Nicholas Saraceno, Jeffrey Bernstein, director of cybersecurity and data privacy for Kaufman Rossin’s risk advisory services, explains the top mistakes healthcare organizations make when building and maintaining their software.

59
article thumbnail

Bring Out Your Meds! Bring Out Your Meds!

The FDA Law Blog

By Larry K. Houck — Eric Idle, as a body collector, immortalized the phrase, “Bring out your dead! Bring out your dead!” in the 1975 comedy classic, Monty Python and the Holy Grail. The Drug Enforcement Administration (“DEA”) would do well to update that phrase as “Bring out your meds! Bring out your meds!” to call attention to the 26th National Prescription Take Back Day.

article thumbnail

A telling chart shows how health insurers found a way to boost profits by limiting care for seniors

STAT

You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money in medicine.  Sign up  to get it in your inbox every Monday. The ‘#1 PRIORITY’ The emails from inside a physician practice owned by UnitedHealth Group sounded cheery, but were all business.

66
article thumbnail

Examining Race-Based Disparities in Access to Multimodal Analgesia

Drug Topics

Multimodal analgesia provides more effective pain management—and leads to a decrease in opioid use.

86
article thumbnail

HLTH24: CopilotIQ, Biofourmis merge to carve out bigger slice of in-home care solutions market

Fierce Healthcare

LAS VEGAS—Health tech companies CopilotIQ and Biofourmis announced a strategic merger on Monday that combines tech-enabled in-home care solutions from pre-surgical optimization to acute, post-acute | Health tech companies CopilotIQ and Biofourmis announced a strategic merger on Monday that combines tech-enabled in-home care solutions from pre-surgical optimization to acute, post-acute and chronic care.

58
article thumbnail

Novo plots US, EU approval filings after oral semaglutide shows cardio benefits in certain diabetes patients

Fierce Pharma

As Novo Nordisk’s injectable diabetes-obesity duo Ozempic and Wegovy grab all the limelight, an oral version of the semaglutide drug showed it can provide heart-related benefits, too. | As Novo Nordisk’s injectable diabetes-obesity duo Ozempic and Wegovy grab all the limelight, an oral version of the semaglutide drug showed it can provide heart-related benefits, too.

57
article thumbnail

STAT+: Pharmalittle: We’re reading about ballooning 340B drug sales, Catalent reassuring customers, and more

STAT

Good morning, everyone, and welcome to another working week. We hope the weekend respite was refreshing and invigorating, because that oh-so familiar routine of online meetings, calls, and deadlines has predictably returned. To cope, we are firing up the coffee kettle in the Pharmalot cafeteria and brewing another cup of stimulation. Our choice today is the seasonal pumpkin spice.

article thumbnail

Education Resources Affect Pharmacy Pneumococcal Vaccination Conversations

Drug Topics

Pharmacist education can positively impact patient counseling around vaccinations in older adults.

86
article thumbnail

American Pharmacists Month: Frank Kessler Reflects on Decades of Work in Community Pharmacy

Pharmacy Times

A dedicated community pharmacist for over 40 years, Kessler has witnessed immense change and innovation throughout his career.